Jennifer J. Rhodes
General Counsel
Elicio Therapeutics, Inc. (ELTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Elicio Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELTX alertsAbout Jennifer J. Rhodes
Jennifer J. Rhodes is recorded as General Counsel at Elicio Therapeutics, Inc. (ELTX). The newest filing on record that lists Jennifer J. Rhodes as General Counsel at Elicio Therapeutics, Inc. (ELTX) is dated April 27, 2022. The proxy statement of Elicio Therapeutics, Inc. reports total compensation of $1,365,859 for Jennifer J. Rhodes in fiscal 2023, including a base salary of $222,257. Disclosed compensation is on record for 2 fiscal years. Acadia Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Elicio Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acadia Pharmaceuticals Inc includes Catherine Owen Adams (CEO and Board Member), Stephen R. Biggar (Chairman and Board Member), Mark C. Schneyer (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2022
-
Acadia Pharmaceuticals Inc (ACAD)
Proxy statement
CurrentStart not stated–present
Last confirmed April 24, 2026
Company network
Leadership on record at Acadia Pharmaceuticals Inc
- Catherine Owen Adams CEO, Board Member
- Stephen R. Biggar Chairman, Board Member
- Mark C. Schneyer CFO
- Mark Schneyer CFO
- Brendan P. Teehan COO
- Austin D. Kim General Counsel
- James K. Kihara Chief Accounting Officer
- Adora Ndu Board Member
- Adora Ndu, Pharm.D., J.D. Board Member
- Daniel B. Soland Board Member
Leadership on record at Elicio Therapeutics, Inc.
- Robert Connelly CEO, Chief Accounting Officer, Board Member
- Julian Adams Chairman
- Julian Adams, Ph.D. Chairman, Board Member
- Brian Piekos CFO
- Preetam Shah, Ph.D., M.B.A. CFO, Chief Accounting Officer
- Allen R. Nissenson Board Member
- Allen R. Nissenson, M.D. Board Member
- Assaf Segal Board Member
- Carol Ashe Board Member
- Jay R. Venkatesan Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Elicio Therapeutics, Inc. (ELTX) | former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary | $222,257 | $1,365,859 |
| 2022 | Elicio Therapeutics, Inc. (ELTX) | former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary | $440,840 | $773,653 |
Recent activity
No call appearances or filed executive changes recorded yet.